パーキンソン病における睡眠障害の病理生理学と薬理学的管理
Cristian Falup-Pecurariu1,2, Larisa Ungureanu1,2, Iulia Murasan2
1Faculty of Medicine, Transilvania University Brasov, Romania.
Journal of Parkinson's disease
|September 2, 2025
まとめ
睡眠障害はパーキンソン病 (PD) でよく見られ,生活の質に影響します. PD睡眠障害のメカニズムの理解は より良い治療法の開発の鍵です
科学分野:
- 神経学
- 睡眠医学
- パーキンソン病の研究
背景:
- 睡眠障害は,パーキンソン病 (PD) の非運動症状である.
- これらの障害には,不眠症,レム睡眠行動障害,不安な足症候群,昼間の過度の眠気などがあります.
- 睡眠障害はPDの進行とともに悪化し,患者の生活の質と他の症状に影響します.
研究 の 目的:
- パーキンソン病における主な睡眠障害の見直し
- 睡眠障害に関する 病理学的洞察を探るため
- PDにおける睡眠障害の管理のための現在のおよび将来の治療戦略について議論する.
主な方法:
- パーキンソン病における睡眠障害に関する文献レビュー
- 提案された病理学的メカニズムの分析.
- 現在の治療法と新たな治療法の評価
主要な成果:
- 睡眠障害はパーキンソン病患者の間で非常に一般的で多様です.
- そのメカニズムには 神経変性,神経伝達物質の機能障害,薬剤の副作用,および昼夜リズム障害が含まれる.
- PDにおける睡眠障害の現在の治療法は限られている.
結論:
- 治療目標の改善のため,病理学的メカニズムに関するさらなる研究が必要である.
- パーキンソン病の睡眠障害に対処するには パーソナライズされた管理戦略が不可欠です
- PDの睡眠障害に対する 新しく効果的な治療法の開発は 満たされていない重要な需要です
関連する概念動画
Parkinson's Disease: Treatment
376
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
376
Parkinson's Disease: Overview
702
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
702
Management of Insomnia
320
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
320
Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response
123
Circadian rhythms are cyclic changes that are crucial in plasma drug concentrations. Various standard circadian parameters, including core body temperature, heart rate, and other cardiovascular factors, directly impact disease states and the therapeutic response to drug therapy.
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
123
REM Sleep Behavior Disorder
387
REM Sleep Behavior Disorder (RBD) is a sleep disorder characterized by the absence of muscle paralysis that normally occurs during the REM phase of sleep. This absence allows individuals to physically act out their dreams, which are often vivid and disturbing. Common behaviors exhibited during episodes include kicking, punching, and yelling. These actions can be dangerous, potentially leading to injuries for the person with RBD or their bed partner.
RBD is significantly associated with...
RBD is significantly associated with...
387
Narcolepsy
197
Narcolepsy is a chronic sleep disorder characterized by pervasive, uncontrolled sleepiness and other sleep disturbances. One of its hallmark symptoms is an abrupt transition to REM sleep upon falling asleep, which causes symptoms typically associated with this phase to occur unexpectedly during wakefulness. These include the following symptoms, which typically last from a minute or two to half an hour.
197


